Haleh Akhavan‐niaki - Genetic Mutations

Author Information

Haleh Akhavan-Niaki is a prominent researcher in the field of genetics, currently affiliated with the Department of Genetics at the Faculty of Medicine, Babol University of Medical Sciences in Babol, Iran. Her work predominantly focuses on various genetic disorders and their molecular characterizations, showcasing her expertise in understanding intricate genetic mechanisms and their implications in medical genetics.

Research Contributions

Haleh Akhavan-Niaki has made significant contributions to the field of genetics, as evidenced by her extensive research portfolio. Her research encompasses a variety of topics including autoimmune syndromes, genetic mutations related to syndromes such as Lowe syndrome, and the molecular mechanisms involved in cancer and viral infections. Notably, she has investigated the genetic aspects of gastric cancer and the implications of new SARS-CoV-2 variants on immune responses. Her work not only adds valuable insights into these complex conditions but also aids in the development of novel diagnostic and therapeutic strategies.

Aliases

Throughout her career, Haleh Akhavan-Niaki has been referred to by several aliases, which include H Akhavan-niaki, Hale Akhavan-niaki, and Haleh Akhavan–niaki. These variations reflect the common discrepancies in name transcription across different publications and databases.

Publication and Citation Metrics

Metric	Value
Citation Count	2294
H-index	24
Paper Count	108

Publications:

Molecular and clinical characterization of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome (APECED) in Iranian non-Jewish patients: report of two novel AIRE gene pathogenic variants

DOI: 10.1186/s13023-021-02170-z

Year: 2022

A deletion mutation along with a novel DNA variation in OCRL cause Lowe syndrome in a child with multiple secondary manifestations.

DOI: 10.18240/ijo.2021.04.25

Year: 2021

Impact of new UK (B.1.1.7) SARS-Cov-2 variant on interacting with ACE2 and host immune response

DOI: 10.1016/j.genrep.2021.101342

Year: 2021

Association of sonic hedgehog signaling pathway genes IHH, BOC, RAB23a and MIR195-5p, MIR509-3-5p, MIR6738-3p with gastric cancer stage

DOI: 10.1038/s41598-021-86946-0

Year: 2021

LINC02688 and PP7080 as novel biomarkers in early diagnosis of gastric cancer

DOI: 10.1016/j.ncrna.2021.04.002

Year: 2021

Patients with Coronary Artery Disease Have Lower Levels of Antibody to Heat-Stressed Fibroblast Derived Proteins, versus Normal Subjects

DOI: 10.1155/2021/5577218

Year: 2021

Author Correction: Association of sonic hedgehog signaling pathway genes IHH, BOC, RAB23a and MIR195-5p, MIR509-3-5p, MIR6738-3p with gastric cancer stage

DOI: 10.1038/s41598-021-95379-8

Year: 2021

No mitigation of IFN-β and HLA class I expression in early sub-cultured human neonatal skin fibroblasts but both molecules are overexpressed in starved cells

DOI: 10.1016/J.GENREP.2021.101085

Year: 2021

Downregulation of Stemness Genes and Induction of Necrosis in Rat LA7 Cancer Stem Cells Induced Tumors Treated with Starved Fibroblasts Culture Supernatant.

DOI: 10.52547/rbmb.10.1.105

Year: 2021

Insights into the Links between MYC and 3D Chromatin Structure and Epigenetics Regulation: Implications for Cancer Therapy

DOI: 10.1158/0008-5472.CAN-20-3613

Year: 2021

What are the Ethical Considerations?

How is the Delta F508 Mutation Inherited?

How are Genetic Mutations Detected?

What Future Research is Needed?

How Do Mutations Affect Genome Stability?

How Can Pharmacogenomics Be Integrated into Clinical Practice?

How Can Radiation Exposure Be Measured?

Are All Silent Mutations Neutral?

What are the Latest Diagnostic Tools?

What is Mutagenesis?

Partnered Content Networks

Relevant Topics